Skip to main content

Table 4 Participant assessments

From: Implementing a pharmacist-integrated collaborative model of medication treatment for opioid use disorder in primary care: study design and methodological considerations

  

3 months pre-PrIMO launch

Launch

3 months post-launch

6 months post-launch

9 months post-launch

12 months post-launch

Site staff participants

 The applied mental health research dissemination and implementation (AMHR) measure

Participant perceptions of model adoption, acceptability, appropriateness, feasibility, reach/access, organizational climate, leadership in implementing, and general leadership skills of the clinic

✓

✓

✓

✓

✓

✓

 Modified clinical sustainability assessment tool (CSAT)

Participant perceptions of the model’s clinical sustainability

 

✓

✓

✓

✓

✓

 The medical conditions regard scale (MCRS)

Biases, emotions, and expectations of chronic medical conditions, including Type2 diabetes, depressive disorder, HIV/AIDS, alcohol use disorder, stimulant use disorder, and opioid use disorder

✓

✓

✓

✓

✓

✓

 Beliefs on MOUD

Prescriber perceptions of and barriers to utilizing MOUD (specifically buprenorphine, methadone, and naltrexone)

✓

✓

✓

✓

✓

✓

 Implementation citizenship behavior scale (ICBS)

Identifies critical behaviors employees exhibit exceeding their expected role to support evidence-based practice implementation

 

✓b

✓b

✓b

✓b

✓b

 Change rulers

Readiness and preparedness to implement PrIMO

✓

✓

✓

✓

✓

✓

 Qualitative interviewsa

Experiences providing care for patients with OUD, including use and knowledge (or lack) of the PrIMO model

✓

✓

 

✓

 

✓

Patient participants

  

Baseline (2 weeks post-exposure)

3 months post-baseline

6 months post-baseline

 Consumer AMHR

Participant perceived acceptability of model adoption, acceptability, appropriateness, feasibility, and reach/access

✓

✓

✓

 Substance use stigma mechanism scale (SU-SMS)

Self-reported feelings of internalized stigma

✓

✓

✓

 Qualitative interviewsa

Experiences receiving care for OUD, including knowledge of the PrIMO model and experiences within the clinic

✓

✓

✓

  1. aFor a subset of enrolled participants
  2. bThe champion provider and pharmacist will complete this measure rating other providers, team members, and pharmacy staff